Amundi Asset Management US’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-379,326
| Closed | -$9.86M | – | 1528 |
|
|
2020
Q4 | $9.86M | Buy |
379,326
+29,923
| +9% | +$778K | 0.01% | 812 |
|
|
2020
Q3 | $13M | Sell |
349,403
-10,061
| -3% | -$374K | 0.01% | 658 |
|
|
2020
Q2 | $18.4M | Buy |
359,464
+41,112
| +13% | +$2.11M | 0.02% | 528 |
|
|
2020
Q1 | $10M | Sell |
318,352
-8,446
| -3% | -$266K | 0.02% | 558 |
|
|
2019
Q4 | $19.5M | Buy |
326,798
+51,645
| +19% | +$3.08M | 0.02% | 574 |
|
|
2019
Q3 | $10.1M | Buy |
275,153
+3,056
| +1% | +$112K | 0.02% | 695 |
|
|
2019
Q2 | $12.7M | Sell |
272,097
-1,580
| -0.6% | -$73.5K | 0.01% | 718 |
|
|
2019
Q1 | $11M | Sell |
273,677
-384
| -0.1% | -$15.4K | 0.02% | 685 |
|
|
2018
Q4 | $12.6K | Sell |
274,061
-69,233
| -20% | -$3.19K | 0.01% | 586 |
|
|
2018
Q3 | $15.2M | Buy |
343,294
+22,479
| +7% | +$997K | 0.02% | 625 |
|
|
2018
Q2 | $12.6M | Buy |
320,815
+26,085
| +9% | +$1.02M | 0.02% | 661 |
|
|
2018
Q1 | $21.3M | Buy |
294,730
+56,346
| +24% | +$4.08M | 0.03% | 462 |
|
|
2017
Q4 | $15.7M | Buy |
238,384
+48,485
| +26% | +$3.19M | 0.02% | 539 |
|
|
2017
Q3 | $9.52M | Buy |
+189,899
| New | +$9.52M | 0.03% | 308 |
|